Focus

Klaria's objective is to combine the Company's patented drug delivery platform with the most relevant and effective substances when it comes to pain relief in the event of migraine and cancer-related breakthrough pain. 

Objective in 2017-2018 is to complete the formulations in all projects and to start testing priority projects in clinical trials.